Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A) is a protein encoded by the human TIMM17A gene. It is an integral membrane protein of the inner mitochondrial membrane and is an essential component of the TIM23 complex that facilitates the translocation of nucleus-encoded and presequence-containing mitochondrial proteins from the cytosol into the mitochondrial matrix. TIMM17A forms the core of the TIM23 complex along with Tim23 and Tim21, creating a channel for protein translocation, and interacts with Tim44 and mitochondrial Hsp70 for further import and sorting[1][2][3][4][5]. TIMM17A is found in all eukaryotes and is highly conserved across species, underscoring its ancient and fundamental role in mitochondrial biogenesis and function. Mutations or dysfunction in this component would disrupt mitochondrial protein import and thereby compromise cellular energy metabolism, but there is no evidence currently linking TIMM17A to specific human disease phenotypes or identifying it as a direct druggable target[3][5][7].
None known. Not a primary drug target[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A).